Type 2 Diabetes Mellitus and Early-Onset Colorectal Cancer: Mechanisms and Herbal Prevention Potential
DOI:
10.29303/jbt.v26i3.11899Published:
2026-07-15Downloads
Abstract
Colorectal cancer is the third most commonly diagnosed cancer and the second leading cause of cancer-related mortality worldwide. The incidence of early-onset colorectal cancer has continued to increase, and type 2 diabetes mellitus (T2DM), particularly chronic hyperglycemia, has been proposed as one of its contributing risk factors. This study aimed to evaluate the potential of herbal compounds as complementary approaches targeting molecular pathways linking T2DM and colorectal cancer. A systematic literature review was conducted following the PRISMA guidelines using PubMed and ScienceDirect. Original articles published between 2021 and 2026, written in English, available in full text, and investigating single herbal compounds or plant extracts in colorectal cancer models were included. The reviewed studies demonstrated that several herbal compounds, including glycyrrhizin, freeze-dried jaboticaba peel, Osmanthus fragrans extract, Ganoderma lucidum polysaccharide, Corallocarpus glomeruliflorus extract, galangin, dictamnine, silymarin, Portulaca oleracea extract, and curcumin, modulated key molecular pathways involved in colorectal carcinogenesis, particularly NF-κB, MAPK, Wnt/β-catenin, and YAP/TAZ signaling. Although these preclinical findings suggest potential complementary roles for herbal bioactive compounds in colorectal cancer prevention, further translational studies and well-designed clinical trials are required to confirm their efficacy and safety in individuals with T2DM.
Keywords:
Colorectal cancer Herbal compounds Young adults Type 2 diabetes mellitusReferences
Al-Haideri, M. (2024). Silymarin suppresses proliferation and PD-L1 expression in colorectal cancer cells and increases inflammatory CD8+ cells in tumor-bearing mice. Clinics and Research in Hepatology and Gastroenterology, 48(8). https://doi.org/10.1016/j.clinre.2024.102425
Bahar, M. E., Kim, H. J., & Kim, D. R. (2023). Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies. In Signal Transduction and Targeted Therapy (Vol. 8, Number 1). Springer Nature. https://doi.org/10.1038/s41392-023-01705-z
Chen, F., Su, J., Liu, Y., Zhang, Z., Li, S., Yuan, Y., & Lai, J. (2026). Targeting YAP/TAZ–TEAD and their protein-protein interaction for precision cancer therapy. In European Journal of Medicinal Chemistry (Vol. 302). Elsevier Masson s.r.l. https://doi.org/10.1016/j.ejmech.2025.118330
Duan, B., Zhao, Y., Bai, J., Wang, J., & Duan, X. (2022). Gastrointestinal Cancers (J. A. Margo-Diaz, Ed.). Exon Publications.
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020). Pathophysiology of type 2 diabetes mellitus. In International Journal of Molecular Sciences, 21(17): 1–34. https://doi.org/10.3390/ijms21176275
Guo, C., Guo, D., Fang, L., Sang, T., Wu, J., Guo, C., Wang, Y., Wang, Y., Chen, C., Chen, J., Chen, R., & Wang, X. (2021). Ganoderma lucidum polysaccharide modulates gut microbiota and immune cell function to inhibit inflammation and tumorigenesis in colon. Carbohydrate Polymers, 267. https://doi.org/10.1016/j.carbpol.2021.118231
Guyton, A. C., & Hall, J. E. (2021). Guyton and Hall Textbook of Medical Physiology 14th Ed (14th ed.). Elsevier. ISBN: 978-0-323-59712-8
Han, S., Lim, S. L., Kim, H., Choi, H., Lee, M. Y., Shim, S. Y., Le, D. D., Ha, I. J., Lee, M., & Lee, S. G. (2024). Ethyl acetate fraction of Osmanthus fragrans var. aurantiacus and its triterpenoids suppress proliferation and survival of colorectal cancer cells by inhibiting NF-κB and COX2. Journal of Ethnopharmacology, 319. https://doi.org/10.1016/j.jep.2023.117362
Khoa Ta, H. D., Nguyen, N. N., Ho, D. K. N., Nguyen, H. D., Ni, Y. C., Yee, K. X., Pan, S. R., Nguyen, H. S., Thai Hoang Phuoc, T., Chen, M. J., & Lee, K. H. (2023). Association of diabetes mellitus with early-onset colorectal cancer: A systematic review and meta-analysis of 19 studies including 10 million individuals and 30,000 events. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 17(8). https://doi.org/10.1016/j.dsx.2023.102828
Lewis, S. T., Greenway, F., Tucker, T. R., Alexander, M., Jackson, L. K., Hepford, S. A., Loveridge, B., & Lakey, J. R. T. (2023). A Receptor Story: Insulin Resistance Pathophysiology and Physiologic Insulin Resensitization’s Role as a Treatment Modality. In International Journal of Molecular Sciences (Vol. 24, Number 13). https://doi.org/10.3390/ijms241310927
Li, J., Pan, J., Wang, L., Ji, G., & Dang, Y. (2025). Colorectal Cancer: Pathogenesis and Targeted Therapy. In MedComm (Vol. 6, Number 3). https://doi.org/10.1002/mco2.70127
Li, Z., Chen, H., Fritz, C. D. L., Zheng, X., Zong, X., Nickel, K. B., Tipping, A., Nguyen, L. H., Chan, A. T., Giovannucci, E. L., Colditz, G. A., Olsen, M. A., Campbell, P. T., Davidson, N. O., Fields, R. C., & Cao, Y. (2022). Type 2 Diabetes and Risk of Early-Onset Colorectal Cancer. Gastro Hep Advances, 1(2), 186–193. https://doi.org/10.1016/j.gastha.2021.10.009
Mao, H., Zhao, X., & Sun, S. C. (2025). NF-κB in inflammation and cancer. In Cellular and Molecular Immunology (Vol. 22, Number 8, pp. 811–839). Springer Nature. https://doi.org/10.1038/s41423-025-01310-w
Młynarska, E., Czarnik, W., Dzieża, N., Jędraszak, W., Majchrowicz, G., Prusinowski, F., Stabrawa, M., Rysz, J., & Franczyk, B. (2025). Type 2 Diabetes Mellitus: New Pathogenetic Mechanisms, Treatment and the Most Important Complications. In International Journal of Molecular Sciences (Vol. 26, Number 3). Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/ijms26031094
Naji Bin-Asal, F. S., Saeed, A. A. M., & Alawi Bin Yahia, A. R. (2025). Corallocarpus glomeruliflorus: Pharmacological potential revealed by phytochemical and in silico investigations. Biochemistry and Biophysics Reports, 41. https://doi.org/10.1016/j.bbrep.2025.101940
Nascimento, R. de P. do, Rizzato, J. S., Polezi, G., Moya, A. M. T. M., Silva, M. F., Machado, A. P. da F., Franchi Junior, G. C., Borguini, R. G., Santiago, M. C. P. de A., Paiotti, A. P. R., Pereira, J. A., Martinez, C. A. R., & Marostica Junior, M. R. (2023). Freeze-dried jaboticaba (Myrciaria jaboticaba) peel powder, a rich source of anthocyanins and phenolic acids, mitigates inflammation-driven colorectal cancer in mice. Food Bioscience, 53. https://doi.org/10.1016/j.fbio.2023.102578
Sha, F., Xin, D., Xu, J., Zheng, Z., Lin, W., Cai, X., Lin, F., Zheng, M., & Chen, J. (2024). Curcumin inhibits colorectal cancer development by blocking the YAP/TAZ signaling axis. Biocell, 48(3), 443–451. https://doi.org/10.32604/biocell.2023.029188
Sung, H., Siegel, R. L., Laversanne, M., Jiang, C., Morgan, E., Zahwe, M., Cao, Y., Bray, F., & Jemal, A. (2025). Colorectal cancer incidence trends in younger versus older adults: an analysis of population-based cancer registry data. The Lancet Oncology, 26(1), 51–63. https://doi.org/10.1016/S1470-2045(24)00600-4
Wang, G., Hiramoto, K., Ma, N., Yoshikawa, N., Ohnishi, S., Murata, M., & Kawanishi, S. (2021). Glycyrrhizin attenuates carcinogenesis by inhibiting the inflammatory response in a murine model of colorectal cancer. International Journal of Molecular Sciences, 22(5), 1–16. https://doi.org/10.3390/ijms22052609
WHO. (2022). World Globocan 2022. https://gco.iarc.who.int/media/globocan/factsheets/populations/900-world-fact-sheet.pdf
Wu, X., Que, H., Li, Q., & Wei, X. (2025). Wnt/β-catenin mediated signaling pathways in cancer: recent advances, and applications in cancer therapy. In Molecular Cancer (Vol. 24, Number 1). BioMed Central Ltd. https://doi.org/10.1186/s12943-025-02363-1
Wu, Y., Luo, J., & Xu, B. (2025). Investigation of galangin against colorectal cancer through MAPK signaling pathway modulation. International Immunopharmacology, 166. https://doi.org/10.1016/j.intimp.2025.115636
Yi, S., Jin, X., Liu, B., Wu, P., Xiao, W., & Chen, W. (2022). Portulaca oleracea extract reduces gut microbiota imbalance and inhibits colorectal cancer progression via inactivation of the Wnt/β-catenin signaling pathway. Phytomedicine, 105. https://doi.org/10.1016/j.phymed.2022.154279
Yu, G. H., Li, S. F., Wei, R., & Jiang, Z. (2022). Diabetes and Colorectal Cancer Risk: Clinical and Therapeutic Implications. In Journal of Diabetes Research (Vol. 2022). Hindawi Limited. https://doi.org/10.1155/2022/1747326
Zuo, X., Lin, H., Song, Z. Y., Yu, B. X., & Zhao, C. (2024). Antitumor activity of dictamnine against colorectal cancer through induction of ferroptosis and inhibition of M2 macrophage polarization via the MAPK signaling. Archives of Biochemistry and Biophysics, 758. https://doi.org/10.1016/j.abb.2024.110051
License
Copyright (c) 2026 Wibisono Hasanul Muhtaram, Mira Nupila Rahma, Ashila Sallama Nur Fadlila, Indri Tiffani, Lalu Abdul Mubarak, Retno Dwi Utami, Baiq Mayada Isqie, Florentcia Davina Gunawan, Made Prajnana Adhi Parasikan Susana, Nensy Dwi Astika, Pande Komang Inten Widya Iswara Oka, Kurniati Kurniati
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
